News

Consilient Health Launches Aripiprazole

02 December 2014
Consilient Health is very proud to announce the launch of its Aripiprazole 5mg, 10mg, 15mg and 30mg tablets in blister packs of 28's. Aripiprazole 5mg, 10mg, 15mg and 30mg tablets are a...

Consilient Health Launches Celecoxib

17 November 2014
Consilient Health is very proud to announce the launch of its Celecoxib 100mg capsules in 60 and 200mg in 30 film-coated tablets.  Celecoxib 100mg and 200mg are a generic of Celebrex®...

Consilient Health Launches Escitalopram

02 June 2014
Consilient Health is very proud to announce the launch of its Escitalopram 5mg, 10mg and 20mg in 28 film-coated tablets.  Escitalopram 5mg, 10mg and 20mg are a generic of...

Consilient Health Launches Cilostazol

25 April 2014
Consilient Health is very proud to announce the launch of its Cilostazol 50mg and 100mg tablets. Cilostazol 50mg and 100mg tablets are a generic of Pletal® 50mg and 100mg tablets and are available...

Consilient Health Launches Tolucombi (Telmisartan/HCTZ)

25 March 2014
Consilient Health is very proud to announce the launch of its Tolucombi® 40mg/12.5mg, 80mg/12.5mg and 80 mg/25mg tablets.     Tolucombi® 40 mg/12.5 mg, 80 mg/12.5mg and 80 mg/25 mg...

Consilient Health launches its new oral contraceptive Lucette®

28 January 2014
February 2014 - Consilient Health Limited launch new oral contraceptive Lucette® (ethinylestradiol 0.03 mg / drospirenone 3 mg) Consilient Health is pleased to announce the launch of Lucette®...

Day 1 Off-Patent - Consilient Health launches Tolura (Telmisartan)

15 December 2013
Consilient Health is very proud to announce the launch of its Tolura 20 mg, 40 mg and 80 mg tablets (Telmisartan). Consilient Health’s Tolura 20 mg, 40 mg, and 80 mg tablets are essentially...

FIRST TO MARKET - Consilient Health Launches Oprymea (Pramipexole)

12 December 2013
Consilient Health is very proud to announce the launch of its Oprymea® 0.26 mg, 0.52 mg, 1.05 mg, 1.57 mg and 2.1 mg prolonged-release tablets (pramipexole). Consilient Health’s Oprymea® 0.26 mg,...

First to Market - Persantin® Retard 200 mg

15 November 2013
Consilient Health is very proud to announce the launch of its Persantin® Retard 200 mg modified-release capsules, hard (dipyridamole). This is an authorised Persantin® Retard 200 mg...

Consilient Health launches Upostelle® (levonorgestrel)

21 October 2013
Consilient Health is very proud to announce the launch of Upostelle®. It has a POM legal category. Upostelle® is indicated for emergency contraception within 72 hours of unprotected sexual...

Corporate Headquarters

Block 2A Richview Office Park
Clonskeagh, Dublin14
Ireland

T. +353 (0)1 2057760
E. info@consilienthealth.com

UK Office

No1 Church Road
Richmond Upon Thames
Surrey
TW9 2QE
UK

T. +44 (0)20 3751 1888
F. +44 (0)20 3751 1889
E. info@consilienthealth.com

For Pharmacovigilance or Medical enquiries please email drugsafety@consilienthealth.com or ring 0203 751 1888.